1997
DOI: 10.1113/expphysiol.1997.sp004017
|View full text |Cite
|
Sign up to set email alerts
|

Effect of the potassium channel opener ZM260384 on skeletal muscle function during restricted blood flow in the anaesthetized cat

Abstract: SUMMARYThe aim of the present experiment was to determine whether the potassium channel opener 2-(2,2-bis(difluoromethyl)-6-nitro-3,4-dihydro-2H-1,4-benzoxazine-4-yl)pyridine-N-oxide (ZM260384) was capable of' accelerating the decline in skeletal muscle function during restricted blood flow in vivo. Cats (3.0-4.5 kg body weight) were anaesthetized with alphaxalone-alphadalone and breathed spontaneously following tracheotomy. Isometric tension was measured in the extensor digitorum longus-anterior tibialis (EDL… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1999
1999
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 14 publications
(23 reference statements)
0
2
0
Order By: Relevance
“…Three papers on work involving cats were published in the area of applied immunology, each studying the epidemiology of a different parasitic infection affecting both cats and humans. A single publication, which was categorised as applied musculoskeletal research, described work on 23 terminally anaesthetised, mature male cats to observe the effects of a potassium channel opener on skeletal muscle function (14).…”
Section: Applied Human Medicinementioning
confidence: 99%
“…Three papers on work involving cats were published in the area of applied immunology, each studying the epidemiology of a different parasitic infection affecting both cats and humans. A single publication, which was categorised as applied musculoskeletal research, described work on 23 terminally anaesthetised, mature male cats to observe the effects of a potassium channel opener on skeletal muscle function (14).…”
Section: Applied Human Medicinementioning
confidence: 99%
“…Benzodihydropyran (BDHP) skeletons ( A , Scheme ) are recognized as privileged substructures pivotal in bioactive molecules and drug discovery Compounds containing a BDHP core feature a natural product‐like scaffold and have high potential in effective drug‐like molecular entities in both biological and synthetic, explorations. Constructions of the BDHP core by formal [4+2] cycloadditions have shown step‐economic routes through reactions of dienophiles with ortho ‐quinone methide (Scheme a) or with oxocarbenium (Scheme b).…”
Section: Introductionmentioning
confidence: 99%